These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16354177)

  • 21. Advances in pemphigus therapy.
    Prajapati V; Mydlarski PR
    Skin Therapy Lett; 2008 Apr; 13(3):4-7. PubMed ID: 18506357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of inhibitors of apoptotic proteins (IAPs) change with IVIg therapy in pemphigus.
    Toosi S; Habib N; Torres G; Reynolds SR; Bystryn JC
    J Invest Dermatol; 2011 Nov; 131(11):2327-9. PubMed ID: 21716321
    [No Abstract]   [Full Text] [Related]  

  • 23. Curative treatment for pemphigus.
    Pasricha JS; Khaitan BK
    Arch Dermatol; 1996 Dec; 132(12):1518-9. PubMed ID: 8961890
    [No Abstract]   [Full Text] [Related]  

  • 24. Coexistence case of bullous pemphigoid and pemphigus foliaceus.
    Tsujiwaki M; Abe R; Nomura Y; Nishimura M; Hoshina D; Shinkuma S; Natsuga K; Ujiie H; Arita K; Shimizu H
    Eur J Dermatol; 2013; 23(4):552-3. PubMed ID: 24001742
    [No Abstract]   [Full Text] [Related]  

  • 25. Verrucous variant of pemphigus foliaceus.
    Ohashi T; Ohtsuka M; Kikuchi N; Yamamoto T
    Clin Exp Dermatol; 2020 Jul; 45(5):584-585. PubMed ID: 31725926
    [No Abstract]   [Full Text] [Related]  

  • 26. Refractory endemic pemphigus foliaceous in adolescence successfully treated with intravenous immunoglobulin.
    Teixeira TA; Fiori FC; Silvestre MC; Borges Cde B; Maciel VG; Costa MB
    An Bras Dermatol; 2011; 86(4 Suppl 1):S133-6. PubMed ID: 22068793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Successful treatment of corticoid-resistant pemphigus with high-dose intravenous immunoglobulins].
    Sibaud V; Beylot-Barry M; Doutre MS; Beylot C
    Ann Dermatol Venereol; 2000 Apr; 127(4):408-10. PubMed ID: 10844264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemphigus vulgaris treated with combined oral cyclosporin and cyclophosphamide.
    Sato N; Satake S; Fujiwara H; Ito M; Kameda K; Nagahori E; Igarashi R
    Clin Exp Dermatol; 1998 Mar; 23(2):92-4. PubMed ID: 9692317
    [No Abstract]   [Full Text] [Related]  

  • 29. Mucocutaneous-type pemphigus vulgaris with anti-desmoplakin autoantibodies.
    Watanabe T; Kato M; Yoshida Y; Fukuda S; Hashimoto T; Yamamoto O
    Eur J Dermatol; 2011; 21(2):299-300. PubMed ID: 21524991
    [No Abstract]   [Full Text] [Related]  

  • 30. Pemphigus vulgaris successfully treated with cyclophosphamide.
    Ebringer A; Mackay IR
    Ann Intern Med; 1969 Jul; 71(1):125-7. PubMed ID: 5791089
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events.
    Seidling V; Hoffmann JH; Enk AH; Hadaschik EN
    Acta Derm Venereol; 2013 May; 93(3):346-9. PubMed ID: 23073990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathological examination of esophagus as a useful criterion of cure in pemphigus vulgaris.
    Torzecka JD; Sysa-Jedrzejowska A; Waszczykowska E; Wozniacka A; Dziankowska-Bartkowiak B; Narbutt J
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):115-8. PubMed ID: 10343938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy.
    Bewley AP; Keefe M
    Br J Dermatol; 1996 Jul; 135(1):128-9. PubMed ID: 8776376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M; Powell AM; Bhogal B; Black MM; Groves RW
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulin for treatment of pemphigus.
    Akerman L; Mimouni D; David M
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):289-94. PubMed ID: 16391404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.
    Boletis JN; Ioannidis JP; Boki KA; Moutsopoulos HM
    Lancet; 1999 Aug; 354(9178):569-70. PubMed ID: 10470708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pemphigus--a model of modern dermatologic research].
    Tappeiner J
    Hautarzt; 1976 Apr; 27(4):181-6. PubMed ID: 931747
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris.
    Green MG; Bystryn JC
    Arch Dermatol; 2008 Dec; 144(12):1621-4. PubMed ID: 19075146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgaris.
    Jolles S; Hughes J; Rustin M
    J Am Acad Dermatol; 1999 Mar; 40(3):499-500. PubMed ID: 10071335
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical uses of intravenous immunoglobulin.
    Jolles S; Sewell WA; Misbah SA
    Clin Exp Immunol; 2005 Oct; 142(1):1-11. PubMed ID: 16178850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.